Advestra advises Sandoz on the placement of inaugural bonds in the equivalent of CHF 2.65 bn. Following its spin-off from Novartis on 4 October 2023, Sandoz,...
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here